BRAINSTORM CELL THERAPEUTICS INC. — Form D

BRAINSTORM CELL THERAPEUTICS INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-09. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Dr. June AlmenoffDirectorNEW YORK, NY
Dr. Irit ArbelDirectorNEW YORK, NY
Dr. Anthony PolverinoDirectorNEW YORK, NY
Chen SchorDirectorNEW YORK, NY
Malcolm TaubDirectorNEW YORK, NY
Uri YablonkaDirectorNEW YORK, NY
Arturo ArayaExecutive OfficerNEW YORK, NY
Ralph KernExecutive OfficerNEW YORK, NY
Chaim LebovitsExecutive OfficerNEW YORK, NY
Eyal RubinExecutive OfficerTEL AVIV, L3
Uri YablonkaExecutive OfficerNEW YORK, NY
Irit ArbelDirectorJERUSALEM, L3
Arturo ArayaDirectorNEW YORK, NY
Mordechai S FriedmanDirectorHackensack, NJ
Anthony S FiorinoExecutive OfficerHackensack, NJ
Alon PinkasDirectorNEW YORK, NY
Uri S YablonkaDirectorHackensack, NJ
Uri S YablonkaExecutive OfficerHackensack, NJ
Liat SossoverExecutive OfficerNEW YORK, NY
Chaim S LebovitsExecutive OfficerHackensack, NJ
Robert ShorrDirectorNEW YORK, NY
Malcolm S TaubDirectorHackensack, NJ
Mordechai FriedmanDirectorNEW YORK, NY
Adrian S. HarelExecutive OfficerNEW YORK, NY
Mordechai S. FriedmanDirectorNEW YORK, NY

Other filings by this issuer (5)

FiledFormOfferingSold
2018-06-20D
2015-01-21D
2014-07-01D$10.5M$10.5M
2014-05-09D$2.5M$1.6M
2012-07-27D$207K$207K

More